nicotine patch drug
Evidence from:
primary |
all sources
Related entities (10)
Mentioned in (8)
Papers in which this entity is mentioned.
- Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions. (2021)
- A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism. (2015)
- Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G. (2014)
- Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. (2013)
- Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: preliminary results using an aggregate genetic risk score. (2012)
- Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. (2012)
- Clinical practice. Treating smokers in the health care setting. (2011)
- Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample. (2009)
Merged raw entities (5)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| nicotine patch | drug | 6 | 14 |
| transdermal nicotine | drug | 4 | 7 |
| 14-mg patch | drug | — | — |
| 21-mg patch | drug | — | — |
| 7-mg patch | drug | — | — |